CMG Pharmaceutical Co. Ltd (058820) — Free Cash Flow Generation Index
CMG Pharmaceutical Co. Ltd (058820) has a Free Cash Flow Generation Index of -28.51x as of December 2024. Free cash flow of ₩-8.27 Billion represents -29% of operating cash flow (₩290.09 Million). Read debt load of CMG Pharmaceutical Co. Ltd for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
CMG Pharmaceutical Co. Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for CMG Pharmaceutical Co. Ltd across 11 annual periods. Explore CMG Pharmaceutical Co. Ltd (058820) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for CMG Pharmaceutical Co. Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for CMG Pharmaceutical Co. Ltd. For the full company profile including market capitalisation, see 058820 company net worth.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -108.44x | ₩-31.46 Billion | ₩290.09 Million | ₩31.75 Billion | ▼ -3639.2% |
| 2023 | -2.90x | ₩-11.34 Billion | ₩3.91 Billion | ₩15.25 Billion | ▼ -166.7% |
| 2022 | -1.09x | ₩-5.37 Billion | ₩4.94 Billion | ₩10.31 Billion | ▼ -464.9% |
| 2021 | 0.30x | ₩1.68 Billion | ₩5.63 Billion | ₩3.95 Billion | ▲ +113.1% |
| 2020 | -2.28x | ₩-6.71 Billion | ₩2.94 Billion | ₩9.65 Billion | ▲ +31.7% |
| 2019 | -3.33x | ₩-9.41 Billion | ₩2.82 Billion | ₩8.18 Billion | ▼ -186.1% |
| 2018 | 3.87x | ₩3.43 Billion | ₩886.78 Million | ₩2.55 Billion | ▲ +178.4% |
| 2017 | 1.39x | ₩2.71 Billion | ₩1.95 Billion | ₩760.59 Million | ▲ +3.3% |
| 2016 | 1.35x | ₩3.11 Billion | ₩2.31 Billion | ₩799.00 Million | ▼ -46.3% |
| 2015 | 2.51x | ₩6.05 Billion | ₩2.41 Billion | ₩3.64 Billion | ▼ -82.1% |
| 2014 | 14.00x | ₩10.15 Billion | ₩724.89 Million | ₩9.42 Billion | — |